MAPT and supranuclear palsy, progressive, 1: In this study, we use progressive supranuclear palsy–Richardson’s syndrome (PSP)24 and corticobasal degeneration (CBD)25 as models of human tauopathy, with relevance to other tau-mediated neurodegenerative disorders, and examine the in vivo relationship between synaptic density and burden of molecular pathology.